Company intelligence / Profile preview

Cayman Pharma

Neratovice, Czech Republic

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Cayman Pharma is a specialized pharmaceutical company focused on the development and manufacture of active pharmaceutical ingredients (APIs), with a world-leading expertise in prostaglandins. Based in the Czech Republic, the company operates as a subsidiary of Cayman Chemical and provides high-quality synthetic prostaglandins for both human and veterinary applications. Their capabilities include complex organic synthesis, purification, and full regulatory support for global markets. Cayman Pharma serves as a key contract development and manufacturing organization (CDMO) for specialized small molecule lipid-based therapeutics.

Therapeutic areas: CardiovascularOphthalmologyWomen's Health
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Cayman Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cayman Pharma.

Explore the full profile